Finance

AMEX accepts Matritech's plan to regain compliance with continued listing standards

Published in Health Business Week, January 12th, 2007

Matritech (MZT), a marketer and developer of protein-based diagnostic products for the early detection of cancer, announced that the American Stock Exchange (AMEX) has accepted the company's plan to regain compliance with continued listing standards of AMEX.

Matritech's plan was submitted in response to a letter from AMEX dated September 21, 2006 in which AMEX informed the company that it was not in compliance with certain continued listing standards, specifically, Section 1003(a)(i) of the company Guide with shareholders' equity of less than $2,000,000 and losses from continuing operations and/or net losses in 2 of its 3 most recent fiscal years, Section 1003(a)(ii) of...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Business Week

Source: Health Business Week (2007-01-12)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry